0 CHECKOUT

Lebanon Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3499809
  • November 2015
  • Region: Lebanon
  • 79 pages
  • Business Monitor International
1 of 4

We hold a bullish outlook for Lebanon's pharmaceutical market, the government's commitment to improving healthcare access coupled with a rising non-communicable disease burden will be a key driving factor for growth over the long-term. However, economic stagnation and political uncertainty made worse by the ongoing civil war in Syria will add downward pressure on our forecast.

Headline Expenditure Projections
- Pharmaceuticals: LBP2.31trn (USD1.53bn) in 2014 to LBP2.47trn (USD1.63bn) in 2015; +6.8% in local currency and +6.4% in US dollar terms. Forecast revised downwards from last quarter based on newly confirmed UN Comtrade data.

- Healthcare: LBP4.97trn (USD3.29bn) in 2014 to LBP5.41trn (USD3.57bn) in 2015; +8.9% in local currency and +8.5% in US dollar terms. Forecast revised upwards from last quarter.

Note: Product cover images may vary from those shown
2 of 4

Table: Headline Pharmaceuticals & Healthcare Forecasts (Lebanon 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2013-2019)

Industry Risk Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

Lebanon Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Developments

Counterfeit Drugs

Public Sector Procurement

Intellectual Property Issues

Free Trade Agreements

Pricing Regime

Reimbursement Regime

Market Overview

Healthcare Sector

Healthcare Insurance

Medical Tourism

Regional Healthcare Collaboration

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmacy Retail Sector

Company Profile

Algorithm

Pharmaline

Demographic Forecast

Lebanon Demographic Forecast
Table: Population Headline Indicators (Lebanon 1990-2025)
Table: Key Population Ratios (Lebanon 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Lebanon 1990-2025)
Table: Population By Age Group (Lebanon 1990-2025)
Table: Population By Age Group % (Lebanon 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Algorithm
Pharmaline

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.